SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-198939
Filing Date
2011-07-27
Accepted
2011-07-27 16:23:50
Documents
11
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 306889
2 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 10308
3 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 10344
4 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 4148
5 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 4155
  Complete submission text file 0001193125-11-198939.txt   1440249

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT chtp-20110630.xml EX-101.INS 117984
7 XBRL TAXONOMY EXTENSION SCHEMA chtp-20110630.xsd EX-101.SCH 14089
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE chtp-20110630_cal.xml EX-101.CAL 27664
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE chtp-20110630_def.xml EX-101.DEF 10730
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE chtp-20110630_lab.xml EX-101.LAB 118312
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE chtp-20110630_pre.xml EX-101.PRE 86600
Mailing Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277
Business Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Filer) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51462 | Film No.: 11990399
SIC: 2836 Biological Products, (No Diagnostic Substances)